Asiaticoside is a triterpene found in Centella that exhibits anti-inflammatory, neuroprotective, cognition enhancing, antipyretic, antioxidative, pro-angiogenic, anticancer chemotherapeutic, and chemopreventive activities. Asiaticoside inhibits melanogenesis by decreasing DNA binding by MITF; as a result, it is occasionally used in skin whitening treatments. Asiaticoside induces apoptosis, increases activation of caspase 3, decreases release of TNF-α and IL-1β, and suppresses tumor development and size in animal models of breast cancer. In animal models of cerebral ischemia/reperfusion, asiaticoside improves memory and learning deficits and decreases levels of IL-6, TNF-α, and IL-1β. Additionally, asiaticoside decreases LPS-induced inflammation and fever, suppresses activity of myeloperoxidase, and increases activity of heme oxygenase 1 (HO-1) in vivo. Asiaticoside exhibits significant wound healing activity in normal as well as delayed healing models, increasing cell migration, attachment, and growth in vitro. Asiaticoside is an active ingredient of Madecassol, marketed in Korea as wound healing agent for traumatic or surgical wounds, burns, skin grafts, fistulas, abnormal retractile or decubitus scars, cutaneomucous lesions in ENT, gynaecology, ulcerous lesions in leprosy, striae distensae, cellulitis, varicose leg ulcers, haemorrhoid..